Status:
COMPLETED
Digital Life Coaching for Myeloma Patients Undergoing Transplantation
Lead Sponsor:
University of California, San Francisco
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is the first study of digital life coaching (DLC) to engage patients during the peri-HCT period that is punctuated by intensive life changes. DLC may circumvent these limitations by combining the...
Detailed Description
Participants will receive unlimited access to Pack Health's DLC platform during a 16-week period encompassing pre-HCT conditioning chemotherapy, post-HCT recovery, and 100-day follow-up. Participants ...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of one of the following (all referred to as MM in this protocol):
- Multiple myeloma (ICD-10 code: C90.0)
- Extramedullary plasmacytoma (ICD-10 code: C90.2)
- Planned receipt of autologous HCT at our institution
- Patients undergoing outpatient HCT will be eligible
- Patients who received chemomobilization will be eligible
- Age ≥ 18, as life coaches employed by the DLC vendor are not currently trained to work with pediatric patients
Exclusion
- Prior autologous HCT for any indication
- Physician-assessed lack of sufficient English proficiency
- Lack of ownership of a personal smartphone
- Any serious and/or unstable pre-existing medical, psychiatric, or other condition that could interfere with participant's safety, provision of informed consent, or compliance with study procedures
Key Trial Info
Start Date :
May 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 25 2021
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04432818
Start Date
May 20 2020
End Date
February 25 2021
Last Update
June 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143